PRAX

SEC source: 0001707657-26-000008 · wk-form4_1783544160.xml · nonDerivative · entry 2

Souza Marcio · CIK 0001707657 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by spouse

Disclosed balance after: 0

F1 · kind: This transaction represents a bona fide gift of common stock to the Souza 2026 Trust.

SEC source: 0001707657-26-000008 · wk-form4_1783544160.xml · nonDerivative · entry 1

Souza Marcio · CIK 0001707657 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 56,495

F1 · kind: This transaction represents a bona fide gift of common stock to the Souza 2026 Trust.

SEC source: 0001930479-26-000003 · wk-form4_1782508155.xml · derivative · entry 16

DeSimone Jill · CIK 0001930479 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,034 shares

Expires 2032-05-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F14 · derivative.exercise_date: This option was fully vested as of May 23, 2025.

SEC source: 0001930479-26-000003 · wk-form4_1782508155.xml · derivative · entry 15

DeSimone Jill · CIK 0001930479 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 8,566 shares

Expires 2034-06-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F13 · derivative.exercise_date: This option was fully vested as of June 5, 2025.

SEC source: 0001930479-26-000003 · wk-form4_1782508155.xml · nonDerivative · entry 14

DeSimone Jill · CIK 0001930479 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,337

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 25, 2026.

F12 · price: The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $315.590 to $316.010. The Reporting Person undertakes to provide upon request from the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.

SEC source: 0001930479-26-000003 · wk-form4_1782508155.xml · nonDerivative · entry 13

DeSimone Jill · CIK 0001930479 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 3,174

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 25, 2026.

F11 · price: The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $314.400 to $315.380. The Reporting Person undertakes to provide upon request from the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.

SEC source: 0001930479-26-000003 · wk-form4_1782508155.xml · nonDerivative · entry 12

DeSimone Jill · CIK 0001930479 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 4,453

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 25, 2026.

F10 · price: The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $313.400 to $314.000. The Reporting Person undertakes to provide upon request from the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.

SEC source: 0001930479-26-000003 · wk-form4_1782508155.xml · nonDerivative · entry 11

DeSimone Jill · CIK 0001930479 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 4,957

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 25, 2026.

F9 · price: The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $312.370 to $313.280. The Reporting Person undertakes to provide upon request from the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.

SEC source: 0001930479-26-000003 · wk-form4_1782508155.xml · nonDerivative · entry 10

DeSimone Jill · CIK 0001930479 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 5,961

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 25, 2026.

F8 · price: The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $311.340 to $312.320. The Reporting Person undertakes to provide upon request from the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.

SEC source: 0001930479-26-000003 · wk-form4_1782508155.xml · nonDerivative · entry 9

DeSimone Jill · CIK 0001930479 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 8,815

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 25, 2026.

F7 · price: The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $310.340 to $311.300. The Reporting Person undertakes to provide upon request from the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.

SEC source: 0001930479-26-000003 · wk-form4_1782508155.xml · nonDerivative · entry 8

DeSimone Jill · CIK 0001930479 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 10,565

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 25, 2026.

F6 · price: The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $308.900 to $309.790. The Reporting Person undertakes to provide upon request from the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.

SEC source: 0001930479-26-000003 · wk-form4_1782508155.xml · nonDerivative · entry 7

DeSimone Jill · CIK 0001930479 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 11,564

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 25, 2026.

F5 · price: The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $307.900 to $308.870. The Reporting Person undertakes to provide upon request from the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.

SEC source: 0001930479-26-000003 · wk-form4_1782508155.xml · nonDerivative · entry 6

DeSimone Jill · CIK 0001930479 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 12,804

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 25, 2026.

F4 · price: The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $306.365 to $307.180. The Reporting Person undertakes to provide upon request from the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.

SEC source: 0001930479-26-000003 · wk-form4_1782508155.xml · nonDerivative · entry 5

DeSimone Jill · CIK 0001930479 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 13,487

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 25, 2026.

F3 · price: The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $305.000 to $305.830. The Reporting Person undertakes to provide upon request from the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.

SEC source: 0001930479-26-000003 · wk-form4_1782508155.xml · nonDerivative · entry 4

DeSimone Jill · CIK 0001930479 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 13,807

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 25, 2026.

F2 · price: The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $302.500 to $303.440. The Reporting Person undertakes to provide upon request from the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.

SEC source: 0001930479-26-000003 · wk-form4_1782508155.xml · nonDerivative · entry 3

DeSimone Jill · CIK 0001930479 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 13,927

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 25, 2026.

SEC source: 0001930479-26-000003 · wk-form4_1782508155.xml · nonDerivative · entry 2

DeSimone Jill · CIK 0001930479 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 13,937

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001930479-26-000003 · wk-form4_1782508155.xml · nonDerivative · entry 1

DeSimone Jill · CIK 0001930479 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 10,903

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001689548-26-000058 · wk-form4_1781299429.xml · derivative · entry 2

KINDLER JEFFREY B · CIK 0001174454 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 648

Underlying: Common Stock · 648 shares

Expires 2036-06-10

F2 · derivative.exercise_date: The shares subject to this option shall vest in twelve (12) equal monthly installments occurring on the 10th day of each month, with the first such installment occurring on July 10, 2026 and the final such installment occurring on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders.

SEC source: 0001689548-26-000058 · wk-form4_1781299429.xml · nonDerivative · entry 1

KINDLER JEFFREY B · CIK 0001174454 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,537

F1 · kind: Mr. Kindler was awarded 1,371 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vest in a single annual installment on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders. The restricted stock units may be settled only by delivering shares of the Issuer's common stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.

SEC source: 0001689548-26-000064 · wk-form4_1781299464.xml · derivative · entry 2

Arbuckle Stuart A · CIK 0001557290 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 648

Underlying: Common Stock · 648 shares

Expires 2036-06-10

F2 · derivative.exercise_date: The shares subject to this option shall vest in twelve (12) equal monthly installments occurring on the 10th day of each month, with the first such installment occurring on July 10, 2026 and the final such installment occurring on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders.

SEC source: 0001689548-26-000064 · wk-form4_1781299464.xml · nonDerivative · entry 1

Arbuckle Stuart A · CIK 0001557290 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,537

F1 · kind: Mr. Arbuckle was awarded 1,371 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vest in a single annual installment on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders. The restricted stock units may be settled only by delivering shares of the Issuer's common stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.

SEC source: 0001689548-26-000063 · wk-form4_1781299458.xml · derivative · entry 2

Chodakewitz Jeffrey · CIK 0001610876 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 648

Underlying: Common Stock · 648 shares

Expires 2036-06-10

F2 · derivative.exercise_date: The shares subject to this option shall vest in twelve (12) equal monthly installments occurring on the 10th day of each month, with the first such installment occurring on July 10, 2026 and the final such installment occurring on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders.

SEC source: 0001689548-26-000063 · wk-form4_1781299458.xml · nonDerivative · entry 1

Chodakewitz Jeffrey · CIK 0001610876 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,371

F1 · kind: Dr. Chodakewitz was awarded 1,371 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vest in a single annual installment on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders. The restricted stock units may be settled only by delivering shares of the Issuer's common stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.

SEC source: 0001689548-26-000062 · wk-form4_1781299452.xml · derivative · entry 2

YOUNG WILLIAM D · CIK 0001217420 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 648

Underlying: Common Stock · 648 shares

Expires 2036-06-10

F2 · derivative.exercise_date: The shares subject to this option shall vest in twelve (12) equal monthly installments occurring on the 10th day of each month, with the first such installment occurring on July 10, 2026 and the final such installment occurring on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders.

SEC source: 0001689548-26-000062 · wk-form4_1781299452.xml · nonDerivative · entry 1

YOUNG WILLIAM D · CIK 0001217420 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,269

F1 · kind: Mr. Young was awarded 1,371 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vest in a single annual installment on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders. The restricted stock units may be settled only by delivering shares of the Issuer's common stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.

SEC source: 0001689548-26-000061 · wk-form4_1781299446.xml · derivative · entry 2

DeSimone Jill · CIK 0001930479 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 648

Underlying: Common Stock · 648 shares

Expires 2036-06-10

F2 · derivative.exercise_date: The shares subject to this option shall vest in twelve (12) equal monthly installments occurring on the 10th day of each month, with the first such installment occurring on July 10, 2026 and the final such installment occurring on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders.

SEC source: 0001689548-26-000061 · wk-form4_1781299446.xml · nonDerivative · entry 1

DeSimone Jill · CIK 0001930479 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,337

F1 · kind: Ms. DeSimone was awarded 1,371 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vest in a single annual installment on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders. The restricted stock units may be settled only by delivering shares of the Issuer's common stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.

SEC source: 0001689548-26-000060 · wk-form4_1781299441.xml · derivative · entry 2

Cudkowicz Merit Ester · CIK 0001856299 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 648

Underlying: Common Stock · 648 shares

Expires 2036-06-10

F2 · derivative.exercise_date: The shares subject to this option shall vest in twelve (12) equal monthly installments occurring on the 10th day of each month, with the first such installment occurring on July 10, 2026 and the final such installment occurring on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders.

SEC source: 0001689548-26-000060 · wk-form4_1781299441.xml · nonDerivative · entry 1

Cudkowicz Merit Ester · CIK 0001856299 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,371

F1 · kind: Dr. Cudkowicz was awarded 1,371 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vest in a single annual installment on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders. The restricted stock units may be settled only by delivering shares of the Issuer's common stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.

SEC source: 0001689548-26-000059 · wk-form4_1781299435.xml · derivative · entry 2

MITCHELL DEAN J · CIK 0001199297 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 648

Underlying: Common Stock · 648 shares

Expires 2036-06-10

F2 · derivative.exercise_date: The shares subject to this option shall vest in twelve (12) equal monthly installments occurring on the 10th day of each month, with the first such installment occurring on July 10, 2026 and the final such installment occurring on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders.

SEC source: 0001689548-26-000059 · wk-form4_1781299435.xml · nonDerivative · entry 1

MITCHELL DEAN J · CIK 0001199297 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,622

F1 · kind: Mr. Mitchell was awarded 1,371 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vest in a single annual installment on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders. The restricted stock units may be settled only by delivering shares of the Issuer's common stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.

SEC source: 0001689548-26-000057 · wk-form4_1781299421.xml · derivative · entry 2

Norden Gregory · CIK 0001405104 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 648

Underlying: Common Stock · 648 shares

Expires 2036-06-10

F2 · derivative.exercise_date: The shares subject to this option shall vest in twelve (12) equal monthly installments occurring on the 10th day of each month, with the first such installment occurring on July 10, 2026 and the final such installment occurring on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders.

SEC source: 0001689548-26-000057 · wk-form4_1781299421.xml · nonDerivative · entry 1

Norden Gregory · CIK 0001405104 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,559

F1 · kind: Mr. Norden was awarded 1,371 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vest in a single annual installment on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders. The restricted stock units may be settled only by delivering shares of the Issuer's common stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.

SEC source: 0001689548-26-000050 · wk-form4_1779241477.xml · nonDerivative · entry 1

Kelly Timothy Edwin · CIK 0001863297 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,167

F1 · kind: These shares were acquired under the Praxis Precision Medicines, Inc. Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

SEC source: 0001781480-26-000008 · wk-form4_1779241385.xml · nonDerivative · entry 1

Sniecinski Megan · CIK 0001781480 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,664

F1 · kind: These shares were acquired under the Praxis Precision Medicines, Inc. Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

SEC source: 0001707657-26-000005 · wk-form4_1779241363.xml · nonDerivative · entry 1

Souza Marcio · CIK 0001707657 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 77,016

F1 · kind: These shares were acquired under the Praxis Precision Medicines, Inc. Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

SEC source: 0001827639-26-000007 · wk-form4_1779241539.xml · nonDerivative · entry 1

Mastrocola Lauren · CIK 0001827639 · Principal Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,572.656

F1 · kind: These shares were acquired under the Praxis Precision Medicines, Inc. Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

SEC source: 0001827760-26-000007 · wk-form4_1779241516.xml · nonDerivative · entry 1

Nemiroff Alex · CIK 0001827760 · General Counsel and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,010.667

F1 · kind: These shares were acquired under the Praxis Precision Medicines, Inc. Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

SEC source: 0001689548-26-000017 · wk-form4_1770760657.xml · derivative · entry 3

KINDLER JEFFREY B · CIK 0001174454 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 224

Underlying: Common Stock · 224 shares

Expires 2036-02-06

F3 · derivative.exercise_date: The shares subject to this option shall vest in equal monthly installments occurring on the 26th day of each month, with the first such installment occurring on February 26, 2026 and the final such installment occurring on the earlier of (i) June 26, 2026 or (ii) the date of the Issuer's 2026 annual meeting of stockholders.

SEC source: 0001689548-26-000017 · wk-form4_1770760657.xml · nonDerivative · entry 2

KINDLER JEFFREY B · CIK 0001174454 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,166

F2 · kind: Mr. Kindler was awarded 478 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vest in a single annual installment on the earlier of (i) June 26, 2026 or (ii) the date of the Issuer's 2026 annual meeting of stockholders. The restricted stock units may be settled only by delivering shares of the Issuer's common stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.

SEC source: 0001689548-26-000017 · wk-form4_1770760657.xml · nonDerivative · entry 1

KINDLER JEFFREY B · CIK 0001174454 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 688

F1 · kind: Mr. Kindler was awarded 688 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vest in two equal annual installments occurring on the first two anniversaries of January 8, 2026. The restricted stock units may be settled only by delivering shares of the Issuer's common stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.

SEC source: 0001689548-26-000018 · wk-form4_1770760770.xml · derivative · entry 3

Arbuckle Stuart A · CIK 0001557290 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 224

Underlying: Common Stock · 224 shares

Expires 2036-02-06

F3 · derivative.exercise_date: The shares subject to this option shall vest in equal monthly installments occurring on the 26th day of each month, with the first such installment occurring on February 26, 2026 and the final such installment occurring on the earlier of (i) June 26, 2026 or (ii) the date of the Issuer's 2026 annual meeting of stockholders.

SEC source: 0001689548-26-000018 · wk-form4_1770760770.xml · nonDerivative · entry 2

Arbuckle Stuart A · CIK 0001557290 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,166

F2 · kind: Mr. Arbuckle was awarded 478 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vest in a single annual installment on the earlier of (i) June 26, 2026 or (ii) the date of the Issuer's 2026 annual meeting of stockholders. The restricted stock units may be settled only by delivering shares of the Issuer's common stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.

SEC source: 0001689548-26-000018 · wk-form4_1770760770.xml · nonDerivative · entry 1

Arbuckle Stuart A · CIK 0001557290 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 688

F1 · kind: Mr. Arbuckle was awarded 688 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vest in two equal annual installments occurring on the first two anniversaries of January 8, 2026. The restricted stock units may be settled only by delivering shares of the Issuer's common stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.

SEC source: 0001863297-26-000005 · wk-form4_1768353511.xml · nonDerivative · entry 1

Kelly Timothy Edwin · CIK 0001863297 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,046

F1 · kind: Shares withheld by the Issuer to satisfy the tax withholding obligations in connection with the vesting of certain previously reported restricted stock units.

SEC source: 0001781480-26-000006 · wk-form4_1768353587.xml · nonDerivative · entry 1

Sniecinski Megan · CIK 0001781480 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,530

F1 · kind: Shares withheld by the Issuer to satisfy the tax withholding obligations in connection with the vesting of certain previously reported restricted stock units.

SEC source: 0001827639-26-000005 · wk-form4_1768353630.xml · nonDerivative · entry 1

Mastrocola Lauren · CIK 0001827639 · Principal Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,445.656

F1 · kind: Shares withheld by the Issuer to satisfy the tax withholding obligations in connection with the vesting of certain previously reported restricted stock units.

SEC source: 0001827760-26-000005 · wk-form4_1768353556.xml · nonDerivative · entry 1

Nemiroff Alex · CIK 0001827760 · General Counsel and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,932.667

F1 · kind: Shares withheld by the Issuer to satisfy the tax withholding obligations in connection with the vesting of certain previously reported restricted stock units.

SEC source: 0001689548-26-000011 · wk-form4_1768258139.xml · nonDerivative · entry 2

Kelly Timothy Edwin · CIK 0001863297 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,989

F2 · kind: Shares withheld by the Issuer to satisfy the tax withholding obligations in connection with the vesting of certain previously reported restricted stock units.